What Is CVS Fair Value?
CVS Health Corporation (CVS) fair value estimate using multiple valuation models, updated daily.
As of August 1, 2026, CVS Health Corporation (CVS) has a composite fair value estimate of $131.04 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $104.43, suggesting the stock is undervalued by 25.5%.
Data as of August 1, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$131.04
vs. current price of $104.43(+25.5%)
How Is CVS Fair Value Calculated?
Four independent models estimate what CVS is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CVS Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$151.17
+44.8%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$145.02
+38.9%Undervalued
Inputs used
CVS Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$101.01
-3.3%Fair Value
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$87.16
-16.5%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $104.43 is 44.8% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $5.81B | $5.46B |
| Year 2 | $6.49B | $5.74B |
| Year 3 | $7.25B | $6.02B |
| Year 4 | $8.10B | $6.32B |
| Year 5 | $9.04B | $6.64B |
| Year 6 | $10.10B | $6.97B |
| Year 7 | $11.28B | $7.32B |
| Year 8 | $12.60B | $7.69B |
| Year 9 | $14.07B | $8.08B |
| Year 10 | $15.72B | $8.48B |
| Terminal Value | $416.64B | $224.74B |
What Are CVS's Key Financial Metrics?
Earnings & Growth
Current Price
$104.43
EPS (TTM)
$2.28
Forward P/E
12.4
Profit Margin
0.7%
Cash & Balance Sheet
Free Cash Flow
5.2B
EBITDA
15.4B
Book Value
$60.85
Total Debt
78.3B
What Do Analysts Say About CVS?
Low
$79.00
Average
$113.50
High
$148.00
Upside
+8.7%
CVS Fair Value FAQ
What is the fair value of CVS?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CVS's estimated fair value is $131.04. The stock is currently trading at $104.43, which makes it undervalued by our analysis.
How is CVS's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CVS overvalued or undervalued?
Based on our analysis, CVS is undervalued. The current price of $104.43 is 25.5% below our estimated fair value of $131.04.
What do Wall Street analysts say about CVS?
26 analysts cover CVS Health Corporation with a consensus rating of "Strong Buy." The average price target is $113.50, ranging from $79.00 to $148.00. This implies 8.7% upside from the current price.